Evidence map›Paper›PMID 19547749›Full record

ArticlePLoS neglected tropical diseases2009

High burden of impetigo and scabies in a tropical country.

Andrew C Steer, Adam W J Jenney, Joseph Kado, Michael R Batzloff, Sophie La Vincente, Lepani Waqatakirewa, E Kim Mulholland, Jonathan R Carapetis

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 3 syntheses or guidelines pooled it, 172 citations in OpenAlex.

  1. Prevalence and determinants of scabies: A global systematic review and meta-analysis.Tropical medicine & international health : TM & IH · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. NVC-422 topical gel for the treatment of impetigo.International journal of clinical and experimental pathology · 2011
    Trial
  11. Article
  12. Article
  13. Myocarditis Following Invasive Group ACase reports in infectious diseases · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Andrew C SteerCentre for International Child Health, University of Melbourne, Melbourne, Australia. andrew.steer@rch.org.au
Adam W J Jenney
Joseph Kado
Michael R Batzloff
Sophie La Vincente
Lepani Waqatakirewa
E Kim Mulholland
Jonathan R Carapetis
University of Melbourne · AUMinistry Of Health · FJLondon School of Hygiene & Tropical Medicine · GBQIMR Berghofer Medical Research Institute · AU

Funding

Global GAS Vaccine Based On The M-ProteinU01AI060579 · NIAID · QUEENSLAND INSTITUTE OF MEDICAL RESEARCH · PI GOOD, MICHAEL F · 2004 to 2008
$2.8M
NIAID NIH HHS U01 AI060579NIAID NIH HHS U01AI60579
6 · The paper itself

Abstract

backgroundImpetigo and scabies are endemic diseases in many tropical countries; however the epidemiology of these diseases is poorly understood in many areas, particularly in the Pacific. METHODOLOGY/PRINCIPAL

findingsWe conducted three epidemiological studies in 2006 and 2007 to determine the burden of disease due to impetigo and scabies in children in Fiji using simple and easily reproducible methodology. Two studies were performed in primary school children (one study was a cross-sectional study and the other a prospective cohort study over ten months) and one study was performed in infants (cross-sectional). The prevalence of active impetigo was 25.6% (95% CI 24.1-27.1) in primary school children and 12.2% (95% CI 9.3-15.6) in infants. The prevalence of scabies was 18.5% (95% CI 17.2-19.8) in primary school children and 14.0% (95% CI 10.8-17.2) in infants. The incidence density of active impetigo, group A streptococcal (GAS) impetigo, Staphylococcus aureus impetigo and scabies was 122, 80, 64 and 51 cases per 100 child-years respectively. Impetigo was strongly associated with scabies infestation (odds ratio, OR, 2.4, 95% CI 1.6-3.7) and was more common in Indigenous Fijian children when compared with children of other ethnicities (OR 3.6, 95% CI 2.7-4.7). The majority of cases of active impetigo in the children in our study were caused by GAS. S. aureus was also a common cause (57.4% in school aged children and 69% in infants). CONCLUSIONS/SIGNIFICANCE: These data suggest that the impetigo and scabies disease burden in children in Fiji has been underestimated, and possibly other tropical developing countries in the Pacific. These diseases are more than benign nuisance diseases and consideration needs to be given to expanded public health initiatives to improve their control.

Indexed as

AdolescentChildChild, PreschoolComorbidityFemaleFijiHumansImpetigoInfantMalePrevalenceScabiesStaphylococcal InfectionsStaphylococcus aureusStreptococcal InfectionsStreptococcus pyogenes

Identifiers

PMID19547749
PMCPMC2694270
OpenAlexW2078183490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.